Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 12, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Novel anti-tuberculosis agents from MCR libraries.

Alexander Dömling1, Sepp Achatz, Barbara Beck

  • 1Department of Pharmaceutical Sciences, University of Pittsburgh, BST3 10019, Pittsburgh, PA 15621, USA. asd30+@pitt.edu

Bioorganic & Medicinal Chemistry Letters
|August 28, 2007
PubMed
Summary

Structure-based design identified novel compounds effective against tuberculosis. This research presents their synthesis and initial biological activity, offering new avenues for anti-tuberculosis drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geometry-dependent interfaces shape NLRP3 pyrin domain assembly.

International journal of biological macromolecules·2026
Same author

An Ugi-Joullié Platform for Medicinally Relevant 1,4-Dihydrobenzothiazines.

ChemMedChem·2026
Same author

One Face, Three Solutions: Structural Convergence in PD-L1 Inhibition across Antibodies, Macrocycles, and Small Molecules.

Journal of medicinal chemistry·2026
Same author

Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension.

ACS pharmacology & translational science·2026
Same author

Ugi-Tetrazole-Derived α‑Aminomethyl Scaffolds Reveal Unexpected Binding Modes in SARS-CoV‑2 3CLpro.

ACS medicinal chemistry letters·2026
Same author

Systematic Expansion of an Ugi-Based Multicomponent Synthesis of Tetrasubstituted Imidazoles.

ACS omega·2026

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Organic Synthesis

Background:

  • Tuberculosis (TB) remains a significant global health challenge, necessitating the development of new therapeutic agents.
  • Existing anti-TB drugs face challenges like drug resistance and toxicity, driving the search for novel chemical entities.

Purpose of the Study:

  • To employ structure-based design principles to create libraries of novel compounds.
  • To synthesize and evaluate the anti-tubercular potential of these newly designed compounds.

Main Methods:

  • Utilized a structure-based drug design approach to guide compound library generation.
  • Performed multi-component reactions for efficient synthesis of diverse molecular structures.
  • Conducted preliminary biological assays to assess anti-tuberculosis activity.

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Related Experiment Videos

Last Updated: Jul 12, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Main Results:

  • Successfully designed and synthesized a library of novel compounds.
  • Identified several potent anti-tuberculosis compounds from the synthesized library.
  • Preliminary biological data indicates promising activity against Mycobacterium tuberculosis.

Conclusions:

  • Structure-based design is an effective strategy for discovering novel anti-tuberculosis agents.
  • The synthesized compounds represent promising leads for further development into anti-TB drugs.
  • Further investigation is warranted to optimize and validate these compounds for therapeutic use.